Keystone Symposium

June 18th, 2019 – Keystone, CO, USA

Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA.

News & Events:

BIO.NRW MEDICA-FORUM

3. Dezember 2019

DGN Kongress 2019

2. Oktober 2019

Seed Investment

6. Mai 2019

CEOs of Priavoid

3. Mai 2019

AD/PD 2019 – Lisbon

26. März 2019

BioRiver Boost! 2018

23. Oktober 2018

The Nobel Prize

5. Oktober 2018

Prof. Willbold´s interview with PharmaVentures

23. Januar 2018

ISO 9001:2015 certification

7. Dezember 2017

Science September 7th, 2017

10. September 2017

Clinical trial with PRI-002

31. Mai 2017